BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12511881)

  • 1. New insights into an enigmatic tumour suppressor.
    Ratcliffe PJ
    Nat Cell Biol; 2003 Jan; 5(1):7-8. PubMed ID: 12511881
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progress in the study of von Hippel-Lindau syndrome].
    Chen F; Wu M
    Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):236-8. PubMed ID: 9596966
    [No Abstract]   [Full Text] [Related]  

  • 3. [File no. 41. VHL (von Hippel-Lindau). Tumor suppressor gene].
    Soussi T
    Bull Cancer; 2000 Nov; 87(11):771-2. PubMed ID: 11190567
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Hippel-Lindau disease: genetic and clinical observations.
    Iliopoulos O
    Front Horm Res; 2001; 28():131-66. PubMed ID: 11443850
    [No Abstract]   [Full Text] [Related]  

  • 6. A PCR generated BsaJ I RFLP in the promoter of the von Hippel-Lindau disease (VHL) tumour suppressor gene.
    Geil L; Semenova E; Lerman MI; Kuzmin I
    Mol Cell Probes; 1998 Oct; 12(5):343-4. PubMed ID: 9778462
    [No Abstract]   [Full Text] [Related]  

  • 7. The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis.
    Barry RE; Krek W
    Trends Mol Med; 2004 Sep; 10(9):466-72. PubMed ID: 15350900
    [No Abstract]   [Full Text] [Related]  

  • 8. Von Hippel-Lindau disease: the role of gene analysis in affected families.
    Riegler P; Huber W; Corradini R; Neumann HP; Glaesker S; Sessa A
    Nephron; 2000 Jan; 84(1):95-7. PubMed ID: 10644921
    [No Abstract]   [Full Text] [Related]  

  • 9. The challenge of kidney lesions in von Hippel-Lindau disease.
    Neumann HP; Riegler P; Huber W; Corradini R; Sessa A; Fontana D; Wetterauer U; Janetschek G
    Contrib Nephrol; 2001; (136):193-207. PubMed ID: 11688380
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of a novel mutation (c279delC) and a polymorphism (c291C>G) in the von Hippel-Lindau gene in Italian patients.
    Moore PS; Antonello D; Martignoni G; Racchini C; Ventrucci M; Scarpa A
    Hum Mutat; 2000 Jun; 15(6):582. PubMed ID: 10862095
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular diagnosis of von Hippel-Lindau disease.
    Murgia A; Martella M; Polli R; Piermarocchi S; Lo Giudice G; Opocher G
    Contrib Nephrol; 2001; (136):263-70. PubMed ID: 11688392
    [No Abstract]   [Full Text] [Related]  

  • 12. Von Hippel-Lindau syndrome: hereditary cancer arising from inherited mutations of the VHL tumor suppressor gene.
    Humphrey JS; Klausner RD; Linehan WM
    Cancer Treat Res; 1996; 88():13-39. PubMed ID: 9239471
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular genetic analysis of von Hippel-Lindau disease by denaturing high-performance liquid chromatography.
    Menegatti E; Ferrone M; Gallone S; Mameli M; Grosso E; Migone N
    Contrib Nephrol; 2001; (136):306-11. PubMed ID: 11688398
    [No Abstract]   [Full Text] [Related]  

  • 14. Von Hippel-Lindau tumor suppressor protein and transcription elongation: new insights into regulation of gene expression.
    Bertherat J
    Eur J Endocrinol; 1996 Feb; 134(2):157, 159. PubMed ID: 8630511
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma.
    Gnarra JR; Duan DR; Weng Y; Humphrey JS; Chen DY; Lee S; Pause A; Dudley CF; Latif F; Kuzmin I; Schmidt L; Duh FM; Stackhouse T; Chen F; Kishida T; Wei MH; Lerman MI; Zbar B; Klausner RD; Linehan WM
    Biochim Biophys Acta; 1996 Mar; 1242(3):201-10. PubMed ID: 8603073
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical review 155: Pheochromocytoma in Von Hippel-Lindau disease.
    Hes FJ; Höppener JW; Lips CJ
    J Clin Endocrinol Metab; 2003 Mar; 88(3):969-74. PubMed ID: 12629069
    [No Abstract]   [Full Text] [Related]  

  • 17. Three novel mutations in the Von Hippel-Lindau tumour suppressor gene in Italian patients.
    Mandich P; Montera M; Bellone E; Trojani A; Daniele S; Ajmar F
    Hum Mutat; 1998; Suppl 1():S268-70. PubMed ID: 9452106
    [No Abstract]   [Full Text] [Related]  

  • 18. [VHL, angiogenesis and renal carcinoma: the puzzle is complete].
    Richard S
    Ann Pathol; 2000 Mar; 20(2):107-9. PubMed ID: 10740003
    [No Abstract]   [Full Text] [Related]  

  • 19. Von Hippel-Lindau disease: how does one gene cause multiple tumors?
    Roach ES
    Neurology; 1999 Jul; 53(1):7-8. PubMed ID: 10408528
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutation of von Hippel-Lindau tumor suppressor gene in a sporadic endolymphatic sac tumor.
    Hamazaki S; Yoshida M; Yao M; Nagashima Y; Taguchi K; Nakashima H; Okada S
    Hum Pathol; 2001 Nov; 32(11):1272-6. PubMed ID: 11727270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.